For BC, especially in cases expressing PD-L1, immunotherapy has been explored and applied, showcasing promising results particularly in combination with chemotherapy, thus offering a beacon of hope for translating the success observed in other cancers to the realm of breast cancer treatment [36]. The gene discussed is CD274; the disease is cancer.